• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种减少皮下植入式心律转复除颤器(S-ICD)系统中不适当治疗的新算法。

A new algorithm to reduce inappropriate therapy in the S-ICD system.

作者信息

Brisben Amy J, Burke Martin C, Knight Bradley P, Hahn Stephen J, Herrmann Keith L, Allavatam Venugopal, Mahajan Deepa, Sanghera Rick, Gold Michael R

机构信息

Boston Scientific Corporation, St. Paul, Minnesota, USA.

Section of Cardiology, Department of Internal Medicine, University of Chicago, Chicago, Illinois, USA.

出版信息

J Cardiovasc Electrophysiol. 2015 Apr;26(4):417-423. doi: 10.1111/jce.12612. Epub 2015 Feb 17.

DOI:10.1111/jce.12612
PMID:25581303
Abstract

INTRODUCTION

The subcutaneous ICD system (S-ICD) has been shown to be a safe and effective treatment for patients at risk for sudden cardiac death. This device reliably detects ventricular tachyarrhythmias with a low incidence of inappropriate shocks for supraventricular arrhythmias. However, T-wave oversensing (TWOS) is more common with the S-ICD compared with transvenous systems. We developed a novel discrimination algorithm to reduce TWOS without compromising tachyarrhythmia discrimination.

METHODS AND RESULTS

The algorithm was developed using a database of recorded episodes, including 244 appropriate therapies for ventricular arrhythmias and 133 episodes with an inappropriate detection due to TWOS, and using a computer model that simulates the S-ICD system. An independent set of data of 161 TWOS episodes, 137 ventricular and 328 supraventricular episodes, was used to validate the algorithm on actual device hardware. The S-ICD performance with the new algorithm was compared with the S-ICD without the new algorithm. Development results showed a decrease in inappropriate charge due to TWOS by 30.7 ± 18%. All ventricular arrhythmias were appropriately detected and the time to appropriate charge initiation was not increased. System validation showed that the new algorithm avoided an inappropriate charge due to TWOS by 39.8 ± 11.4%. No decrease in ventricular arrhythmia sensitivity and no significant change in supraventricular specificity were observed.

CONCLUSIONS

A new algorithm that uses correlation of the existing complex to previous complexes reduced TWOS episodes by approximately 40%. The algorithm has potential for a clinically meaningful decrease in inappropriate shocks.

摘要

引言

皮下植入式心律转复除颤器系统(S-ICD)已被证明是一种治疗心脏性猝死风险患者的安全有效方法。该设备能可靠地检测室性快速心律失常,对室上性心律失常进行不适当电击的发生率较低。然而,与经静脉系统相比,S-ICD的T波过度感知(TWOS)更为常见。我们开发了一种新的鉴别算法,以减少TWOS,同时不影响快速心律失常的鉴别。

方法与结果

该算法是利用一个记录事件数据库开发的,该数据库包括244次针对室性心律失常的适当治疗以及133次因TWOS导致的不适当检测事件,并使用了一个模拟S-ICD系统的计算机模型。一组独立的数据,包括161次TWOS事件、137次室性事件和328次室上性事件,用于在实际设备硬件上验证该算法。将采用新算法的S-ICD性能与未采用新算法的S-ICD进行比较。开发结果显示,因TWOS导致的不适当充电减少了30.7±18%。所有室性心律失常均被适当检测到,且适当充电启动时间未增加。系统验证表明,新算法避免了因TWOS导致的不适当充电,比例为39.8±11.4%。未观察到室性心律失常敏感性降低,室上性特异性也无显著变化。

结论

一种利用现有复合波与先前复合波相关性的新算法使TWOS事件减少了约40%。该算法有可能在临床上显著减少不适当电击。

相似文献

1
A new algorithm to reduce inappropriate therapy in the S-ICD system.一种减少皮下植入式心律转复除颤器(S-ICD)系统中不适当治疗的新算法。
J Cardiovasc Electrophysiol. 2015 Apr;26(4):417-423. doi: 10.1111/jce.12612. Epub 2015 Feb 17.
2
Inappropriate subcutaneous implantable cardioverter-defibrillator shocks due to T-wave oversensing can be prevented: implications for management.因T波过度感知导致的不适当皮下植入式心律转复除颤器电击可被预防:对管理的启示
Heart Rhythm. 2014 Mar;11(3):426-34. doi: 10.1016/j.hrthm.2013.12.007. Epub 2013 Dec 7.
3
Head-to-head comparison of arrhythmia discrimination performance of subcutaneous and transvenous ICD arrhythmia detection algorithms: the START study.皮下和经静脉 ICD 心律失常检测算法的心律失常鉴别性能的头对头比较:START 研究。
J Cardiovasc Electrophysiol. 2012 Apr;23(4):359-66. doi: 10.1111/j.1540-8167.2011.02199.x. Epub 2011 Oct 28.
4
A fully automatic, implantable cardioverter-defibrillator algorithm to prevent inappropriate detection of ventricular tachycardia or fibrillation due to T-wave oversensing in spontaneous rhythm.一种全自动植入式心脏复律除颤器算法,可防止因自发节律中 T 波过感而导致的室性心动过速或颤动的不适当检测。
Heart Rhythm. 2012 Apr;9(4):522-30. doi: 10.1016/j.hrthm.2011.11.023. Epub 2011 Nov 15.
5
Mechanisms and management of inappropriate therapy in subcutaneous implantable cardioverter defibrillators.皮下植入式心律转复除颤器中不适当治疗的机制和管理。
J Cardiovasc Electrophysiol. 2019 Mar;30(3):402-409. doi: 10.1111/jce.13831. Epub 2019 Jan 6.
6
Eligibility of Pacemaker Patients for Subcutaneous Implantable Cardioverter Defibrillators.起搏器患者植入皮下植入式心律转复除颤器的适应证
J Cardiovasc Electrophysiol. 2017 May;28(5):544-548. doi: 10.1111/jce.13182. Epub 2017 Mar 6.
7
Low Prevalence of Inappropriate Shocks in Patients With Inherited Arrhythmia Syndromes With the Subcutaneous Implantable Defibrillator Single Center Experience and Long-Term Follow-Up.植入式皮下除颤器治疗遗传性心律失常综合征患者的低比例不适当电击:单中心经验和长期随访。
J Am Heart Assoc. 2017 Oct 17;6(10):e006265. doi: 10.1161/JAHA.117.006265.
8
Use of a discrimination algorithm to reduce inappropriate shocks with a subcutaneous implantable cardioverter-defibrillator.使用一种鉴别算法来减少皮下植入式心脏复律除颤器的不适当电击。
Heart Rhythm. 2014 Aug;11(8):1352-8. doi: 10.1016/j.hrthm.2014.04.012. Epub 2014 Apr 13.
9
Long-Term Experience With the Subcutaneous Implantable Cardioverter-Defibrillator in Teenagers and Young Adults.青少年和年轻成人中皮下植入式心脏复律除颤器的长期经验
JACC Clin Electrophysiol. 2017 Dec 26;3(13):1499-1506. doi: 10.1016/j.jacep.2017.08.017. Epub 2017 Nov 6.
10
Postoperative ergometry-guided programming does not prevent T-wave oversensing and inappropriate shocks in S-ICD patients.术后运动负荷试验引导的程控不能预防皮下植入式心律转复除颤器(S-ICD)患者的T波感知过度和不适当电击。
Pacing Clin Electrophysiol. 2018 Jun;41(6):567-571. doi: 10.1111/pace.13327. Epub 2018 Apr 25.

引用本文的文献

1
Inappropriate shock from P-wave oversensing and QRS diminution in a subcutaneous implantable cardioverter defibrillator.皮下植入式心律转复除颤器因P波感知过度和QRS波振幅降低导致不适当电击。
HeartRhythm Case Rep. 2024 Oct 5;11(1):34-37. doi: 10.1016/j.hrcr.2024.09.023. eCollection 2025 Jan.
2
Premature ventricular contraction detection and estimation of daily burden by an insertable cardiac monitor.通过植入式心脏监测器检测室性早搏并估计每日负担
Heart Rhythm O2. 2025 Jan 11;6(4):528-536. doi: 10.1016/j.hroo.2025.01.004. eCollection 2025 Apr.
3
S-ICD Implantation "Tips and Tricks".
皮下植入式心律转复除颤器(S-ICD)植入术“技巧与窍门”
Rev Cardiovasc Med. 2023 Jul 10;24(7):195. doi: 10.31083/j.rcm2407195. eCollection 2023 Jul.
4
Superior vena cava obstruction and cardiovascular implantable electronic devices-a new era of leadless devices.上腔静脉阻塞与心血管植入式电子设备——无导线设备的新时代。
Mediastinum. 2023 Dec 12;8:1. doi: 10.21037/med-23-33. eCollection 2024.
5
Comparison of Preoperative ECG Screening and Device-Based Vector Analysis in Patients Receiving a Subcutaneous Implantable Cardioverter-Defibrillator.比较接受皮下植入式心脏除颤器患者的术前心电图筛查和基于设备的向量分析。
Medicina (Kaunas). 2023 Dec 16;59(12):2186. doi: 10.3390/medicina59122186.
6
The Subcutaneous Implantable Cardioverter-Defibrillator: A Patient Perspective.皮下植入式心脏复律除颤器:患者视角
J Clin Med. 2023 Oct 22;12(20):6675. doi: 10.3390/jcm12206675.
7
Design and rationale of the MODULAR ATP global clinical trial: A novel intercommunicative leadless pacing system and the subcutaneous implantable cardioverter-defibrillator.MODULAR ATP全球临床试验的设计与原理:一种新型的可相互通信的无导线起搏系统和皮下植入式心律转复除颤器。
Heart Rhythm O2. 2023 Jun 2;4(7):448-456. doi: 10.1016/j.hroo.2023.05.004. eCollection 2023 Jul.
8
Exploiting SMART pass filter deactivation detection to minimize inappropriate subcutaneous implantable cardioverter defibrillator therapies: a real-world single-centre experience and management guide.利用 SMART 被动滤波器去激活检测以最小化不适当的皮下植入式心脏复律除颤器治疗:真实世界单中心经验和管理指南。
Europace. 2023 May 19;25(5). doi: 10.1093/europace/euad040.
9
Evolution of extravascular implantable cardioverter-defibrillator therapy for ventricular arrhythmias.用于室性心律失常的血管外植入式心脏复律除颤器治疗的发展历程。
Heart Rhythm O2. 2022 Nov 13;4(1):59-64. doi: 10.1016/j.hroo.2022.09.021. eCollection 2023 Jan.
10
The subcutaneous implantable cardioverter-defibrillator should be considered for all patients with an implantable cardioverter-defibrillator indication.对于所有有植入式心脏复律除颤器适应症的患者,均应考虑植入皮下植入式心脏复律除颤器。
Heart Rhythm O2. 2022 Oct 21;3(5):589-596. doi: 10.1016/j.hroo.2022.09.006. eCollection 2022 Oct.